Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
2(67%)
Results Posted
100%(1 trials)

Phase Distribution

Ph phase_1
3
100%

Phase Distribution

3

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution3 total trials
Phase 1Safety & dosage
3(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

3

all time

Status Distribution
Active(2)
Completed(1)

Detailed Status

Recruiting1
Completed1
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
2
Success Rate
100.0%
Most Advanced
Phase 1

Trials by Phase

Phase 13 (100.0%)

Trials by Status

recruiting133%
completed133%
active_not_recruiting133%

Recent Activity

2 active trials
Showing 3 of 3
completedphase_1

Proof-of-concept Study With NVDX3 for Treatment of Distal Radius Fractures.

NCT05987033
active_not_recruitingphase_1

Study With NVDX3 for Treatment of Low Grade Degenerative Lumbar Spondylolisthesis

NCT05961956
recruitingphase_1

Long-term Safety Trial with NVDX3

NCT06532253

Clinical Trials (3)

Showing 3 of 3 trials
NCT05987033Phase 1

Proof-of-concept Study With NVDX3 for Treatment of Distal Radius Fractures.

Completed
NCT05961956Phase 1

Study With NVDX3 for Treatment of Low Grade Degenerative Lumbar Spondylolisthesis

Active Not Recruiting
NCT06532253Phase 1

Long-term Safety Trial with NVDX3

Recruiting

All 3 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
3